日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Noncanonical functions of UGT2B17 promote castration-resistant prostate cancer progression.

UGT2B17 的非经典功能促进去势抵抗性前列腺癌的进展。

Feng Tingting, Xie Ning, Gao Lin, Jia Qiongqiong, Kung Sonia Hy, Morova Tunc, Li Yinan, Wang Lin, Fazli Ladan, Lacombe Louis, Guillemette Chantal, Lévesque Eric, Lack Nathan A, Qi Jianfei, Han Bo, Dong Xuesen

Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiation.

纵向单细胞分析揭示 RUNX1T1 是治疗诱导的神经内分泌转分化的早期驱动因素

Ni Yuchao, Lin Dong, Shi Mingchen, Lin Yen-Yi, Xue Hui, Dong Xin, Liu Liangliang, Sar Funda, Wu Rebecca, Morova Tunc, Haegert Anne, Bell Robert, Pang Xinyao, Classen Adam, Wang Yu, Chen Junru, Volik Stanislav, Bihan Stéphane Le, Lack Nathan, Ong Christopher, Wang Gang, Zeng Hao, Collins Colin, Wang Yuzhuo

Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours

姜黄酚具有一种不寻常的组蛋白去乙酰化酶增强活性,可对抗转移性肿瘤的免疫逃逸。

Ellis, Samantha L S; Dada, Sarah; Nohara, Lilian L; Saranchova, Iryna; Munro, Lonna; Pfeifer, Cheryl G; Eyford, Brett A; Morova, Tunc; Williams, David E; Cheng, Ping; Lack, Nathan A; Andersen, Raymond J; Jefferies, Wilfred A

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

EPIKOL 是一个基于 CRISPR/Cas9 的染色质靶向筛选平台,用于识别癌症特异性的表观遗传脆弱性。

Yedier-Bayram, Ozlem; Gokbayrak, Bengul; Kayabolen, Alisan; Aksu, Ali Cenk; Cavga, Ayse Derya; Cingöz, Ahmet; Kala, Ezgi Yagmur; Karabiyik, Goktug; Günsay, Rauf; Esin, Beril; Morova, Tunc; Uyulur, Fırat; Syed, Hamzah; Philpott, Martin; Cribbs, Adam P; Kung, Sonia H Y; Lack, Nathan A; Onder, Tamer T; Bagci-Onder, Tugba